Annual D&A
$8.05M$776.00K+10.67%
Summary
- Current Value
- As of today, DVAX annual D&A is $8.05M, up +10.67% on
- Historical Performance
- DVAX annual D&A is up +14.85% over the past 3 years, and down -62.60% over the past 5 years
- All-Time High Comparison
- DVAX annual D&A is currently -62.60% below its historical high of $21.53M set on
- 3-Year Low Comparison
- DVAX annual D&A is +20.76% above its 3-year low of $6.67M reached on an earlier date
- Sector Comparison
- DVAX annual D&A is higher than 69.52% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $8.05M | +10.7% | +14.8% | -62.6% | +183.8% | |
| Quarterly D&A | $2.09M | +1.9% | +40.5% | +19.8% | +256.1% | |
| TTM D&A | $8.24M | +3.8% | +18.8% | -29.1% | +227.5% | |
| Price | $15.41 | +22.1% | +50.0% | +208.8% | -52.9% | |
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual Total Expenses | $249.94M | +4.7% | -31.5% | +33.1% | +252.6% | |
| Annual Operating Expenses | $231.92M | +7.3% | +77.8% | +80.0% | +1434.4% | |
| Annual Revenue | $277.25M | +19.4% | -36.6% | +687.2% | +587.6% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $8.05M | at high | |
| 5Y | $9.34M | N/A | -13.7% |
| All | $21.53M | -62.6% |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $6.67M | N/A | +20.8% |
| 5Y | $6.67M | +20.8% | |
| All | $223.00K | +3510.8% |
Depreciation & Amortization History
FAQ
What is the current annual D&A of DVAX?
As of today, DVAX annual D&A is $8.05M
What is 1-year change in DVAX annual D&A?
DVAX annual D&A is up +10.67% year-over-year
What is 3-year change in DVAX annual D&A?
DVAX annual D&A is up +14.85% over the past 3 years
How far is DVAX annual D&A from its all-time high?
DVAX annual D&A is currently -62.60% below its historical high of $21.53M set on December 31, 2019
How does DVAX annual D&A rank versus sector peers?
DVAX annual D&A is higher than 69.52% of companies in Healthcare sector
When is DVAX next annual earnings release?
The next annual earnings release for DVAX is on
Quarterly D&A
$2.09M$55.00K+2.70%
Summary
- Current Value
- As of today, DVAX quarterly D&A is $2.09M, up +2.70% on
- Historical Performance
- DVAX quarterly D&A is up +1.95% year-over-year, and up +40.54% over the past 3 years
- All-Time High Comparison
- DVAX quarterly D&A is currently -72.67% below its historical high of $7.66M set on
- 3-Year Low Comparison
- DVAX quarterly D&A is +44.51% above its 3-year low of $1.45M reached on an earlier date
- Sector Comparison
- DVAX quarterly D&A is higher than 67.41% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $2.09M | +2.7% | +1.9% | +40.5% | +19.8% | |
| Annual D&A | $8.05M | – | +10.7% | +14.8% | -62.6% | |
| TTM D&A | $8.24M | +0.5% | +3.8% | +18.8% | -29.1% | |
| Price | $15.41 | +48.9% | +22.1% | +50.0% | +208.8% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly Total Expenses | $67.95M | -11.4% | +7.8% | -34.6% | +653.9% | |
| Quarterly Operating Expenses | $59.20M | -11.6% | +3.0% | +32.8% | +101.8% | |
| Quarterly Revenue | $94.88M | -0.6% | +17.7% | -43.4% | +607.3% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.09M | at high | |
| 3Y | $2.09M | at high | |
| 5Y | $2.09M | at high | |
| All | $7.66M | -72.7% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.04M | +2.9% | |
| 3Y | $1.45M | N/A | +44.5% |
| 5Y | $1.45M | +44.5% | |
| All | -$1.01M | +307.1% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of DVAX?
As of today, DVAX quarterly D&A is $2.09M
What is DVAX quarterly D&A most recent change?
DVAX quarterly D&A was up +2.70% on September 30, 2025
What is 1-year change in DVAX quarterly D&A?
DVAX quarterly D&A is up +1.95% year-over-year
How far is DVAX quarterly D&A from its all-time high?
DVAX quarterly D&A is currently -72.67% below its historical high of $7.66M set on September 30, 2019
How does DVAX quarterly D&A rank versus sector peers?
DVAX quarterly D&A is higher than 67.41% of companies in Healthcare sector
When is DVAX next earnings release?
The next earnings release for DVAX is on
TTM D&A
$8.24M$40.00K+0.49%
Summary
- Current Value
- As of today, DVAX TTM D&A is $8.24M, up +0.49% on
- Historical Performance
- DVAX TTM D&A is up +3.79% year-over-year, and up +18.78% over the past 3 years
- All-Time High Comparison
- DVAX TTM D&A is currently -61.73% below its historical high of $21.53M set on
- 3-Year Low Comparison
- DVAX TTM D&A is +29.01% above its 3-year low of $6.39M reached on
- Sector Comparison
- DVAX TTM D&A is higher than 67.32% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $8.24M | +0.5% | +3.8% | +18.8% | -29.1% | |
| Annual D&A | $8.05M | – | +10.7% | +14.8% | -62.6% | |
| Quarterly D&A | $2.09M | +2.7% | +1.9% | +40.5% | +19.8% | |
| Price | $15.41 | +48.9% | +22.1% | +50.0% | +208.8% | |
| TTM SG&A | -$3.84B | -2200.4% | -2356.2% | -3060.3% | -4794.4% | |
| TTM Revenue | $330.51M | +4.5% | +26.7% | -54.9% | +779.7% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $8.24M | at high | |
| 3Y | $8.24M | at high | |
| 5Y | $9.34M | N/A | -11.7% |
| All | $21.53M | -61.7% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $8.05M | N/A | +2.3% |
| 3Y | $6.39M | +29.0% | |
| 5Y | $6.39M | +29.0% | |
| All | -$455.00K | +1911.0% |
TTM D&A History
FAQ
What is the current TTM D&A of DVAX?
As of today, DVAX TTM D&A is $8.24M
What is DVAX TTM D&A most recent change?
DVAX TTM D&A was up +0.49% on September 30, 2025
What is 1-year change in DVAX TTM D&A?
DVAX TTM D&A is up +3.79% year-over-year
How far is DVAX TTM D&A from its all-time high?
DVAX TTM D&A is currently -61.73% below its historical high of $21.53M set on December 31, 2019
How does DVAX TTM D&A rank versus sector peers?
DVAX TTM D&A is higher than 67.32% of companies in Healthcare sector
When is DVAX next earnings release?
The next earnings release for DVAX is on
Data Sources & References
- DVAX Official Website www.dynavax.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1029142/000162828025049536/0001628280-25-049536-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1029142/000102914225000049/0001029142-25-000049-index.htm
- DVAX Profile on Yahoo Finance finance.yahoo.com/quote/DVAX
- DVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dvax